Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 3
2019 5
2020 3
2021 3
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Current trends in luminescence-based assessment of apoptosis.
Moldovan C, Onaciu A, Toma V, Munteanu RA, Gulei D, Moldovan AI, Stiufiuc GF, Feder RI, Cenariu D, Iuga CA, Stiufiuc RI. Moldovan C, et al. Among authors: moldovan ai. RSC Adv. 2023 Oct 30;13(45):31641-31658. doi: 10.1039/d3ra05809c. eCollection 2023 Oct 26. RSC Adv. 2023. PMID: 37908656 Free PMC article. Review.
Gold nanorods: from anisotropy to opportunity. An evolution update.
Onaciu A, Braicu C, Zimta AA, Moldovan A, Stiufiuc R, Buse M, Ciocan C, Buduru S, Berindan-Neagoe I. Onaciu A, et al. Among authors: moldovan a. Nanomedicine (Lond). 2019 May;14(9):1203-1226. doi: 10.2217/nnm-2018-0409. Epub 2019 May 10. Nanomedicine (Lond). 2019. PMID: 31075049 Review.
Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome.
Jurj A, Pop L, Petrushev B, Pasca S, Dima D, Frinc I, Deak D, Desmirean M, Trifa A, Fetica B, Gafencu G, Selicean S, Moisoiu V, Micu WT, Berce C, Sacu A, Moldovan A, Colita A, Bumbea H, Tanase A, Dascalescu A, Zdrenghea M, Stiufiuc R, Leopold N, Tetean R, Burzo E, Tomuleasa C, Berindan-Neagoe I. Jurj A, et al. Among authors: moldovan a. Crit Rev Clin Lab Sci. 2018 Nov;55(7):501-515. doi: 10.1080/10408363.2018.1499707. Epub 2018 Sep 21. Crit Rev Clin Lab Sci. 2018. PMID: 30238808 Review.
Targeting Cell Death Mechanism Specifically in Triple Negative Breast Cancer Cell Lines.
Pruteanu LL, Braicu C, Módos D, Jurj MA, Raduly LZ, Zănoagă O, Magdo L, Cojocneanu R, Paşca S, Moldovan C, Moldovan AI, Ţigu AB, Gurzău E, Jäntschi L, Bender A, Berindan-Neagoe I. Pruteanu LL, et al. Among authors: moldovan ai. Int J Mol Sci. 2022 Apr 26;23(9):4784. doi: 10.3390/ijms23094784. Int J Mol Sci. 2022. PMID: 35563174 Free PMC article.
Aberrant miRNAs expressed in HER-2 negative breast cancers patient.
Braicu C, Raduly L, Morar-Bolba G, Cojocneanu R, Jurj A, Pop LA, Pileczki V, Ciocan C, Moldovan A, Irimie A, Eniu A, Achimas-Cadariu P, Paradiso A, Berindan-Neagoe I. Braicu C, et al. Among authors: moldovan a. J Exp Clin Cancer Res. 2018 Oct 20;37(1):257. doi: 10.1186/s13046-018-0920-2. J Exp Clin Cancer Res. 2018. PMID: 30342533 Free PMC article.
Hsa-miR-125b Therapeutic Role in Colon Cancer Is Dependent on the Mutation Status of the TP53 Gene.
Cenariu D, Zimta AA, Munteanu R, Onaciu A, Moldovan CS, Jurj A, Raduly L, Moldovan A, Florea A, Budisan L, Pop LA, Magdo L, Albu MT, Tonea RB, Muresan MS, Ionescu C, Petrut B, Buiga R, Irimie A, Gulei D, Berindan-Neagoe I. Cenariu D, et al. Among authors: moldovan a. Pharmaceutics. 2021 May 6;13(5):664. doi: 10.3390/pharmaceutics13050664. Pharmaceutics. 2021. PMID: 34066331 Free PMC article.
20 results